Literature DB >> 670398

Multiple forms of human plasma renin substrate.

P Eggena, H Hidaka, J D Barrett, M P Sambhi.   

Abstract

The objective of this investigation was to determine whether heterogeneity of plasma renin substrate could be observed in states of steroid excess and various forms of hypertensive disease. In states of stimulated renin substrate production by estrogens or glucocorticoids, multiple forms of renin substrate were apparent when stimulation was excessive. Stimulation of substrate production caused by uremia associated with hypertension showed similar results. None, or only trace quantities of the additional forms of renin substrate were evident in subjects with normal or suppressed levels of plasma renin substrate. The additional forms of renin substrate could be distinguished from the normal form on the basis of cross-reactivity with a specific antiserum to the normal form, electrophoretic mobility, and kinetic rate constants. Differences in rate constants of the various forms of plasma renin substrate may account for the altered rate of the renin reaction associated with several states of hypertension. In plasma of patients with renovascular hypertension, significant quantities of a protein which cross-reacted with the antiserum but could not generate angiotensin I were observed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 670398      PMCID: PMC371774          DOI: 10.1172/JCI109137

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  Influence of angiotensinase ihhibitors on the enzymatic activity of renin.

Authors:  J D Barrett; P Eggena; M P Sambhi
Journal:  Biochem Med       Date:  1976-10

2.  A direct radioimmunoassay for human renin substrate and identification of multiple substrate types in plasma.

Authors:  P Eggena; J D Barrett; H Hidaka; C L Chu; C Thananopavarn; M S Golub; M P Sambhi
Journal:  Circ Res       Date:  1977-10       Impact factor: 17.367

3.  Heterogeneity of renin substrate in human plasma: effect of pregnancy and oral contraceptives.

Authors:  D B Gordon; I N Sachin; V N Dodd
Journal:  Proc Soc Exp Biol Med       Date:  1976-11

4.  Resolution of multiple forms of human angiotensinogen. Isoelectric focusing heterogeneity profile analysis.

Authors:  M P Printz; J M Printz; J A Lewicki; T Gregory
Journal:  Circ Res       Date:  1977-10       Impact factor: 17.367

5.  The validity of comparing the measurements of angiotensin I generated in human plasma by radioimmunoassay and bioassay.

Authors:  P Eggena; J D Barrett; M P Sambhi; C E Wiedeman
Journal:  J Clin Endocrinol Metab       Date:  1974-11       Impact factor: 5.958

6.  Effects of oral contraceptive therapy on the renin-angiotensin system.

Authors:  M D Cain; W A Walters; K J Catt
Journal:  J Clin Endocrinol Metab       Date:  1971-10       Impact factor: 5.958

7.  Extraction, purification, and assay of human renin free of angiotensinase.

Authors:  E Haas; H Goldblatt; E C Gipson; L Lewis
Journal:  Circ Res       Date:  1966-10       Impact factor: 17.367

8.  Hypertension induced by oral contraceptives containing estrogen and gestagen. Effects on plasma renin activity and aldosterone excretion.

Authors:  M H Weinberger; R D Collins; A J Dowdy; G W Nokes; J A Luetscher
Journal:  Ann Intern Med       Date:  1969-11       Impact factor: 25.391

9.  A circulating renin activator in essential hypertension.

Authors:  M P Sambhi; P Eggena; J C Barrett; M Tuck; C E Wiedeman; C Thananopavarn
Journal:  Circ Res       Date:  1975-06       Impact factor: 17.367

10.  Renin activation in the venous plasma from the involved kidney in the patient with renal hypertension.

Authors:  M P Sambhi; C E Wiedeman
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

View more
  3 in total

1.  Hypertension symposium: newer topics on normal and abnormal blood pressure regulatory mechanisms.

Authors:  M L Tuck; M S Golub; P Eggena; J R Sowers; M Maxwell
Journal:  West J Med       Date:  1983-08

2.  Characterization of precursor and secreted forms of human angiotensinogen.

Authors:  D J Campbell; J Bouhnik; E Coezy; J Menard; P Corvol
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

Review 3.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.